Loading...

LUCA Science Announces $9.8 Million Series A Financing to Support Research and Development of Functional Mitochondria as Therapeutic Agents

Print Friendly, PDF & Email

LUCA Science Inc. (Graphic: Business Wire) TOKYO–( BUSINESS WIRE )–LUCA Science, a company developing functional mitochondria as therapeutic agents, an emerging platform to treat damaged tissues and organs, today announced the closing of a $9.8 million Series A financing. The funding round was led by Axil Capital Partners. Additional […]